← Back to Search

"Relax" descriptor for Cannabis Use

N/A
Waitlist Available
Led By Beth Reboussin, PhD
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Aged 18-65, inclusive
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up after exposure to product packaging up to 1 minute
Awards & highlights

Study Summary

This trial looks at people's reactions to cannabis edibles, and how product descriptions affect their opinion.

Who is the study for?
This trial is for individuals who are interested in or have experience with cannabis use. Specific eligibility criteria to participate are not provided, so it's unclear who exactly can join.Check my eligibility
What is being tested?
The study aims to understand how different descriptions on cannabis edibles packaging influence people's opinions about the product, including its appeal and perceived harm, as well as their willingness to try these products.See study design
What are the potential side effects?
Since this trial focuses on perceptions rather than physical effects of consumption, side effects related to the interventions (product descriptors) are not applicable.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 65 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~after exposure to product packaging up to 1 minute
This trial's timeline: 3 weeks for screening, Varies for treatment, and after exposure to product packaging up to 1 minute for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Harm Perceptions (Absolute)
Product Appeal Responses
Willingness to Try Product
Secondary outcome measures
Appeal to Children Responses
Harm Perceptions (Relative)
Other outcome measures
Perception of Quality Responses

Trial Design

10Treatment groups
Experimental Treatment
Group I: No descriptor (control)Experimental Treatment1 Intervention
Four edible product packages (gummies, chocolate, mints, cookies) without any product descriptors
Group II: "Vegan" descriptorExperimental Treatment1 Intervention
Four edible product packages (gummies, chocolate, mints, cookies) with the product descriptor "Vegan"
Group III: "Relax" descriptorExperimental Treatment1 Intervention
Four edible product packages (gummies, chocolate, mints, cookies) with the product descriptor "Relax"
Group IV: "Made with live resin" descriptorExperimental Treatment1 Intervention
Four edible product packages (gummies, chocolate, mints, cookies) with the product descriptor "Made with live resin"
Group V: "Handcrafted" descriptorExperimental Treatment1 Intervention
Four edible product packages (gummies, chocolate, mints, cookies) with the product descriptor "Handcrafted"
Group VI: "Gluten-free" descriptorExperimental Treatment1 Intervention
Four edible product packages (gummies, chocolate, mints, cookies) with the product descriptor "Gluten-free"
Group VII: "Fast-acting" descriptorExperimental Treatment1 Intervention
Four edible product packages (gummies, chocolate, mints, cookies) with the product descriptor "Fast-acting"
Group VIII: "Energy Boost" descriptorExperimental Treatment1 Intervention
Four edible product packages (gummies, chocolate, mints, cookies) with the product descriptor "Energy Boost"
Group IX: "All Natural" descriptorExperimental Treatment1 Intervention
Four edible product packages (gummies, chocolate, mints, cookies) with the product descriptor "All Natural."
Group X: "100% Organic" descriptorExperimental Treatment1 Intervention
Four edible product packages (gummies, chocolate, mints, cookies) with the product descriptor "100% Organic"
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
No descriptor (control)
2024
N/A
~2740
"Relax" descriptor
2024
N/A
~2740
"Made with live resin" descriptor
2024
N/A
~2740
"Fast-acting" descriptor
2024
N/A
~2740
"Energy Boost" descriptor
2024
N/A
~2740
"Gluten-free" descriptor
2024
N/A
~2740
"Vegan" descriptor
2024
N/A
~2740
"Handcrafted" descriptor
2024
N/A
~2740
"All Natural" descriptor
2024
N/A
~2740
"100% Organic" descriptor
2024
N/A
~2740

Find a Location

Who is running the clinical trial?

National Institute on Drug Abuse (NIDA)NIH
2,485 Previous Clinical Trials
2,619,649 Total Patients Enrolled
28 Trials studying Cannabis Use
3,657 Patients Enrolled for Cannabis Use
Wake Forest University Health SciencesLead Sponsor
1,250 Previous Clinical Trials
1,004,447 Total Patients Enrolled
1 Trials studying Cannabis Use
1,250 Patients Enrolled for Cannabis Use
Beth Reboussin, PhDPrincipal InvestigatorWake Forest University Health Sciences
1 Previous Clinical Trials
1,250 Total Patients Enrolled
1 Trials studying Cannabis Use
1,250 Patients Enrolled for Cannabis Use
~1821 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top